Eltrombopag in Chronic ITP

Status:
Unknown status

Trial end date:
2021-01-01

Target enrollment:

Participant gender:

This study aims to evaluate the efficacy of eltrombopag on the platelet count in pediatric patients with chronic immune thrombocytopenia.

Phase 4

Assiut University